Neurology· Topic 10.11 Multiple sclerosis and neuro-ophthalmic disorders· 10.11.2

Transverse myelitis

Transverse myelitis is inflammation across one or more contiguous spinal cord segments causing subacute weakness, a sensory level, and bladder or bowel dysfunction; diagnosis requires spinal MRI showing cord enhancement or CSF inflammation with exclusion of compressive and infectious causes, and idiopathic disease is treated with high-dose intravenous methylprednisolone.

13 min read2 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: transverse myelitis is an inflammatory, often demyelinating, disorder of the spinal cord affecting one or more contiguous segments, producing motor, sensory, and autonomic dysfunction below the level of the lesion.

  • Epidemiology

    Age distribution: ITM has a bimodal distribution, with peaks in adolescence/young adulthood and again in middle to older adulthood.

  • Risk factors

    Recent infection: a preceding viral syndrome or bacterial infection increases risk through a postinfectious immune-mediated mechanism.

  • Pathophysiology

    Immune-mediated cord inflammation: in idiopathic and postinfectious cases, an aberrant immune response, likely triggered by molecular mimicry between a preceding pathogen and myelin or axonal…

  • Clinical features

    Core triad: subacute limb weakness, a sensory level (a discrete band below which sensation is impaired), and bladder or bowel dysfunction are the defining features.

  • Differential diagnosis

    Compressive myelopathy (epidural abscess, tumor, disc herniation, spinal hematoma): shows cord compression rather than intrinsic enhancement without compression on MRI; must be excluded emergently…

  • Diagnosis

    Establishing basis: the diagnosis requires the clinical syndrome above plus objective evidence of cord inflammation (gadolinium enhancement on MRI or cerebrospinal fluid pleocytosis/elevated IgG…

  • Management

    First step: exclude, and if present urgently treat, a compressive cause of myelopathy before starting immunosuppression, since glucocorticoids do not address mechanical cord compression and delay to decompression worsens outcomes.

  • Complications

    Permanent motor and sensory deficits: a substantial proportion of patients are left with residual weakness, sensory disturbance, or gait impairment, particularly when the initial deficit was complete paraplegia or slow to begin improving.

  • Prognosis

    Recovery trajectory: most improvement in ITM occurs over the first 3 to 6 months, though some recovery can continue for up to 2 years.

  • Prevention

    No established primary prevention for idiopathic disease: because the trigger for most idiopathic and postinfectious transverse myelitis is not a modifiable exposure, there is no proven strategy to prevent a first episode.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.